帕金森病与自身免疫病之间的全基因组多效性
结果识别出17个错误发现率小于0.05的新多效性位点,复制证实HLA、LRRK2、MAPT、TRIM10和SETD1A参与帕金森病,部分新位点与邻近基因甲基化或表达变化相关。
要点
- 帕金森病与多种自身免疫病存在共享遗传风险变异,支持免疫机制参与帕金森病。
- 全基因组分析识别17个新多效性位点,复制证实HLA、LRRK2、MAPT等参与帕金森病。
- WNT3、KANSL1等新基因与已知帕金森病基因存在蛋白互作,部分位点影响甲基化或表达。
核心结论
- 帕金森病与自身免疫病之间存在共同的遗传通路,提示免疫相关机制可能参与帕金森病。
研究设计与样本
- 使用NeuroX数据(6927例帕金森病病例和6108例对照)进行复制。
- 通过蛋白-蛋白相互作用及基因表达和甲基化水平变化探究顶级位点的生物学相关性。
主要发现
- 全基因组联合分析识别出17个错误发现率小于0.05的新位点,在帕金森病与自身免疫病之间存在重叠。
- 已知帕金森病位点GAK、HLA-DRB5、LRRK2和MAPT与类风湿关节炎、溃疡性结肠炎和克罗恩病重叠。
- 复制证实HLA、LRRK2、MAPT、TRIM10和SETD1A参与帕金森病。
- 新基因WNT3、KANSL1、CRHR1、BOLA2和GUCY1A3与已知帕金森病基因位于蛋白-蛋白相互作用网络中。
- 部分新位点与邻近基因的甲基化或表达水平变化显著相关。
临床怎么用
- 研究结果提示抗炎药物未来治疗试验可能具有意义,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standing observations of an association between immune-mediated diseases and Parkinson disease (PD). The post-GWAS era provides an opportunity for cross-phenotype analyses between different complex phenotypes. OBJECTIVES: To test the hypothesis that there are common genetic risk variants conveying risk of both PD and autoimmune diseases (ie, pleiotropy) and to identify new shared genetic variants and their pathways by applying a novel statistical framework in a genome-wide approach. DESIGN, SETTING, AND PARTICIPANTS: Using the conjunction false discovery rate method, this study analyzed GWAS data from a selection of archetypal autoimmune diseases among 138 511 individuals of European ancestry and systemically investigated pleiotropy between PD and type 1 diabetes, Crohn disease, ulcerative colitis, rheumatoid arthritis, celiac disease, psoriasis, and multiple sclerosis. NeuroX data (6927 PD cases and 6108 controls) were used for replication. The study investigated the biological correlation between the top loci through protein-protein interaction and changes in the gene expression and methylation levels. The dates of the analysis were June 10, 2015, to March 4, 2017. MAIN OUTCOMES AND MEASURES: The primary outcome was a list of novel loci and their pathways involved in PD and autoimmune diseases. RESULTS: Genome-wide conjunctional analysis identified 17 novel loci at false discovery rate less than 0.05 with overlap between PD and autoimmune diseases, including known PD loci adjacent to GAK, HLA-DRB5, LRRK2, and MAPT for rheumatoid arthritis, ulcerative colitis and Crohn disease. Replication confirmed the involvement of HLA, LRRK2, MAPT, TRIM10, and SETD1A in PD. Among the novel genes discovered, WNT3, KANSL1, CRHR1, BOLA2, and GUCY1A3 are within a protein-protein interaction network with known PD genes. A subset of novel loci was significantly associated with changes in methylation or expression levels of adjacent genes. CONCLUSIONS AND RELEVANCE: The study findings provide novel mechanistic insights into PD and autoimmune diseases and identify a common genetic pathway between these phenotypes. The results may have implications for future therapeutic trials involving anti-inflammatory agents.
引用
- Witoelar A, Jansen IE, Wang Y, et al. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. JAMA Neurol. 2017. PMID: 28586827. doi:10.1001/jamaneurol.2017.0469
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。